Going Digital: A Survey on Digitalization and Large-Scale Data Analytics in Healthcare

Abstract

We provide an overview of the recent trends towards digitalization and large scale data analytics in healthcare. It is expected that these trends are instrumental in the dramatic changes in the way healthcare will be organized in the future. We discuss the recent political initiatives designed to shift care delivery processes from paper to electronic, with the goals of more effective treatments with better outcomes; cost pressure is a major driver of innovation. We describe newly developed networks of healthcare providers, research organizations and commercial vendors to jointly analyze data for the development of decision support systems. We address the trend towards continuous healthcare where health is monitored by wearable and stationary devices; a related development is that patients increasingly assume responsibility for their own health data. Finally we discuss recent initiatives towards a personalized medicine, based on advances in molecular medicine, data management, and data analytics.

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes

“…One of the challenges with neoepitope discovery and targeting will be the management of Big Data: teraflops of compute resources in a cloud environment to generate terabytes of sequencing data, including whole genome and/or whole exome sequencing, RNA sequencing, and molecular modeling of immune presentation of neoepitopes [53]. To meet the demands of heterogeneity, analysis and long-term storage of data from multiple biopsies for each patient is a further challenge.…”

Translationale Highlights Mamma- und Ovarialkarzinom 2019 – Immuntherapien, DNA-Reparatur, PI3K-Inhibition und CDK4/6-Therapien

“…Technologien, die große Datenmengen mit Methoden des maschinellen Lernens oder des Deep Learning untersuchen, werden immer mehr in der Medizin angewendet und implementiert [38]. Anwendungen, die sich teilweise bereits in der Entwicklung befinden, könnten somit in naher Zukunft einen direkten Einfluss auf die klinische Praxis haben.…”

Update Mammakarzinom 2019 Teil 2 – Implementierung neuer Diagnostika und Therapien bei Patientinnen mit fortgeschrittenem Brustkrebs in der klinischen Praxis

“…computerunterstützte Verwaltung. Der Support des Arztes durch Systeme, die möglicherweise durch maschinelles Lernen unterstützt werden, könnte ein Ansatz sein, diese Big-Data-Analysen in die klinische Praxis einzuführen [103,104].…”